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ABSTRACT 
 
The number of people in immediate need of anti-retroviral treatment (ART) in the southern 
African region continues to significantly exceed the capacity of health systems to provide it.  
Approaches to this complex rationing dilemma have evolved in different directions.  The ethical 
concepts of fairness and equity have been suggested as a basis guiding rationing or patient 
selection processes for ART.  The purpose of the study was to examine whether or not such 
concepts had relevance or operative value for a treatment team providing ART in rural Lesotho.  
Using an exploratory, single case study design the study found that while concepts of fairness 
and equity were relevant to the work of the treatment team, patient selection practices did not 
necessarily reflect what these concepts entail.  The idea of fairness as a structured, formalized 
selection process did not figure in the approach to ART provision at St. Charles.  A less formal, 
‘first-come-first-served’ approach was adopted.  While there was knowledge amongst some team 
members that social, economic or geographic conditions inhibit individuals and groups from 
gaining access to ART and that this was inequitable, it was felt that there was little they could do 
to try to mediate the impact of these conditions.   The study findings pose importance questions 
about the approach to ART programming in resource constrained settings.  The findings also 
question the relevance of trying to achieve fairness and equity when the gap between need for 
care and capacity to provide it remains so large. 
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SELECTING PATIENTS FOR ANTI-RETROVIRAL CARE AT A RURAL CLINIC IN LESOTHO:  
RESULTS FROM A CASE STUDY ANALYSIS 
 
Introduction  
 
 
It is now more than three years since anti-retroviral treatment (ART) for people living with 
HIV/AIDS was made widely available in the public sector across the southern African region.  
The number of people in need of immediate treatment continues to exceed by a significant 
margin the capacity of health systems to provide it.  In South Africa, for example, it was 
estimated that in 2006, 520,000 individuals were in need of immediate access to ART while only 
124,000 were receiving it (Stewart, Padarath, Milford 2006: 287). By mid-2006, the number of 
those receiving treatment had increased to 200,000 while those in immediate need stood at 
711,000 (Dorrington et al, 2007:  27, 29).  Similarly in Lesotho, where an estimated 23.2% of the 
population is HIV-positive (UNAIDS 2006), it was estimated in 2007 that 81,270 individuals 
were in need of treatment and only 31,808 were receiving it (GoL 2007a:  52, 53).  In these 
assessments, those considered in need of treatment already experience advance symptoms of 
HIV disease.   Most of these individuals have only limited time before their condition becomes 
unresponsive to the range of anti-retroviral therapies (ARVs) available in the region.   
 
While it was known at the beginning of the regional effort to provide ART that not all those in 
need of treatment would receive it, effective ways of selecting those HIV-positive individuals  
who should go first and those who should continue to wait have not developed as was originally 
anticipated.  Despite the creation of model eligibility criteria and selection processes by teams of 
experts associated with the World Health Organization (WHO 2004a), the advice of prominent 
legal and ethical scholars (Macklin 2004; Daniels 2004), and consensus statements by globally 
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representative multi-stakeholder groups (WHO 2004b), approaches to this complex rationing 
dilemma have evolved in different directions.  This study examines the patient selection process 
at an ART program operating in a rural area of Lesotho.  The experience of the treatment team is 
enlightening.  It challenges the practical value of the theoretical approaches to patient selection 
originally articulated by the World Health Organization and others.  It suggests the need for 
much deeper ethical reflection and ongoing questioning of the dominant approach to ART 
provision in Lesotho and elsewhere.  Finally, it raises anew the far greater challenge of global 
health inequity and whether current efforts to treat HIV in resource-limited settings can 
effectively address and resolve it. 
 
Background 
 
In 2004, the World Health Organization (WHO 2004b) proposed some clinical and social criteria 
to assist in selecting patients for ART in settings were need was greater than capacity.  In 
general, the criteria targeted individuals who were already experiencing advanced symptoms of 
HIV-disease.  The criteria also targeted those individuals who were most likely to be able to take 
ART regularly and correctly over their lifetime in order to maximize the health benefits of 
treatment.   In settings like South Africa or Lesotho, however, these have proved insufficient as 
effective rationing criteria (Rosen et al. 2005: 354).  The number of individuals who meet the 
eligibility criteria continues to exceed spaces available for treatment in many settings.  There is a 
step between those who are eligible and those who actually gain access to treatment which is a 
much more explicit process of patient selection that was not part of the WHO model.  Very few 
programs, if any, have attempted this step.  Stewart et al. (2006: 298), noting the large gap 
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between need and availability throughout South Africa, lamented the absence of more explicit 
patient selection strategies and the resulting form of indirect or implicit rationing that is 
occurring there: 
 
“Currently this rationing is indirect and implicitly favours those who are informed, can 
afford it, are in proximity to facilities, and/or have time to wait in queues.  In some 
instances, clinicians are forced to make choices as to who can or cannot receive 
treatment, decisions they are ill-equipped to handle.  Implicit rationing is likely to 
increase the inequity in provision of, and access to services, while undercutting the 
potential societal benefits of the programme.” 
 
In the absence of explicit guidelines, the rationing dilemma falls at the feet of the health care 
providers in treatment programs.  The conclusions of Bennett and Chanfreau (2005: no page), 
reviewing rationing strategies for ARV treatment programmes in Mexico, Senegal, Thailand and 
Uganda, were that: 
 
“…if rationing criteria are left vague and poorly defined, then allocation is more likely to 
be driven by implicit rationing, whereby individual decision makers use their own values 
or professional judgements to determine who gains access to care.” 
 
These studies affirmed that patient selection strategies in addition to those proposed by WHO 
would be required to address the gap between need and availability of ART.  Such strategies 
needed to be in the form of guidelines or other directives above the level of the treatment team or 
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the individual health care provider.  Otherwise, ad-hoc approaches would evolve that were not 
sufficient to achieve an effective distribution of the benefits of ART.  Ad-hoc approaches could 
even compromise the ability of treatment programs more generally to effectively mitigate the 
larger, more devastating social and economic impacts of HIV/AIDS in settings like southern 
Africa.   
 
What form should selection strategies take?  Within the specific context of providing ART in 
resource-limited settings, Ruth Macklin (2004) and Norman Daniels (2004) have provided 
detailed advice.  David McCoy (2003) and Kalanda et al. (2004), through Equinet,1 also 
contributed to the debate.  The legal and ethical concepts of equity and fairness link the different 
perspectives.  Macklin (2004:  4-6), addressing equity, described the need to chose between 
different principles of equity and to develop corresponding approaches to patient selection.  
Signalling that a ‘first-come-first-served’ approach to equity might not be the best choice, she 
put forward three other approaches to equity for consideration:  
 
 utilitarian or provide treatment to the greatest number of those who will derive the greatest 
benefit; 
 egalitarian or aim for equitable distribution of resources or benefits (including providing 
more to some groups in order to reduce disparities in health status); and, 
 maximin or prioritarian which is to give preference to those who are worse off in some 
material respect (the sickest, for example, or the poorest or the most marginalized) while 
                                                          
1   Equinet is the Regional Network on Equity in Health in Southern Africa, a network of professionals, civil society 
members, policy makers, state officials and others within the region who act as an equity catalyst to promote and 
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others who are comparatively more advantage continue to wait. 
 
‘First-come-first-served’ approaches may be effective in contexts where those who need a 
benefit share comparative or relative equity but not where the gap between the amount of benefit 
available and the amount of need for it is as stark as it is in southern Africa settings in relation to 
ART.  Consider the case of a ship that founders with only limited space on life-boats.  Some 
additional selection criteria are usually applied with a view to trying to preserve some essential 
aspects of the group or community that is at risk.  In addition, it is considered unfair and 
inequitable that those who get seats in boats are those who are closest, who can run faster or who 
have knowledge of where the boats are.  It is for these reasons that other approaches to equitable 
selection should be considered.   
 
Macklin (2004: 3), in her argument, stepped back, however, from recommending which 
approach should be followed in relation to ART programs.  She noted only that the decision 
would be complex and difficult and that the ethical debate on rationing problems offers no clear 
guidance on which principles or values should predominate.   Macklin made her views known at 
the outset of large scale implementation of ART programs in countries like Lesotho where HIV-
prevalence was extremely high, the epidemic was generalized throughout the population, and the 
need for ART was acute and overwhelming.  She acknowledged the possibility that governments 
and others in these settings might not chose an explicit approach to equity and, moreover, would 
not directly commit themselves to offering ART to some groups in the population and not others.  
Rather, they might chose an indirect approach to selection by simply offering what limited ART 
                                                                                                                                                                                           
realise shared values of equity and social justice in health.  See  http://www.equinetafrica.org   
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that was available to whoever gained access to the treatment programs first.  As a result, the 
substantive equity she desired for the scaling-up of ART in southern Africa and elsewhere would 
not be achieved (ibid.: 2). 
 
In order to avoid such an outcome, Macklin (2004: 12) concluded her advice with an emphasis 
on the need for formal, inclusive, deliberative processes at all levels of ART delivery to decide 
which of the available approaches to equity should guide patient selection.   In this respect, she 
relied on Norman Daniels’ approach to rationing problems.  In earlier work, Daniels (Daniels, 
Sabin 2002) argued for a reliance on principles of procedural justice when faced with the 
dilemma of not knowing which values or other criteria should guide rationing decisions.  Where 
there was not enough ART for all who needed it, according to Daniels, there could be no 
substantively fair outcome.  Some would get treatment and others would not.  All that could be 
aspired to in this setting would be a fair process of choosing between those in need.  This led him 
to propose his “accountability for reasonableness” model as a tool to assist in the development of 
patient selection processes and rationing strategies (Daniels 2004: ii-iv).  According to the 
model, provided the selection process was procedurally fair, and was viewed as such by all 
involved, even those who did not benefit from the outcome would still accept the selecting 
decision.  As Daniels (Daniels, Sabin 2002: 4) stated: 
 
“In the absence of broadly accepted consensus on principles of fair distribution, the 
problem of fair allocation becomes one of procedural justice.  The basic idea behind this 
appeal to procedural justice is quite familiar.  When we lack consensus on principles that 
tell us what is fair, or even when we have general principles but are burdened by 
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reasonable disagreements about how they apply, we may nevertheless find a process or 
procedure that most can accept as fair to those who are affected by such decisions.  That 
fair process then determines for us what counts as a fair outcome.”   
 
This approach was created in the context of rationing dilemmas in developed countries where the 
issues at stake were predominately access to advanced technological interventions or those still 
in the experimental stage.  When Daniels recommended this approach in the context of rationing 
access to ART, it had not, as yet, been tested in a settings like Lesotho where the rationing 
dilemma affects a substantial portion of the population, where the impact of HIV-related 
morbidity and mortality on the social and economic viability of the country is significant in the 
absence of treatment programs, and where such an evolved conception of distributive justice in 
terms of health care resources has not necessarily taken hold within the national approach to 
providing ART.    
 
Researchers at Equinet were more direct in their response to the challenge of patient selection for 
ART.  McCoy (2003), for example, argued for a particular type of equity as the only effective 
outcome of patient selection processes.   Formally, equity was the absence of discrimination in 
an ART program on the basis of arbitrary or non-relevant criteria. Substantively, it was the 
alleviation of unfair or avoidable health inequalities or disparities in the distribution of ART 
through a ‘fair share’ rather than an ‘equal share’ approach.  As he stated (McCoy 2003: 11), 
“Equity implies an approach that gives more to those who have little, and thus less to those who 
have much.”  Practically this meant using concentrated efforts to break through the barriers of 
health inequities by, in effect, prioritizing the provision of ART towards those least able to 
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access health care services or to benefit from health care resources.  It also meant limiting or 
refusing access to those with comparative social or economic advantages who were able to 
obtain ART from alternative sources.  McCoy (2003: 11) warned that unless proactive attempts 
were made to ensure equity, the distribution of ART was likely to follow the path of existing 
inequities and not to benefit those in greatest need.  Loewenson and McCoy (2004:  242; McCoy 
2003:  42) went further to suggest that, in the extreme, corruption and abuse within treatment 
programs could also occur in the absence of explicit efforts to promote equity and to protect 
access to treatment for those who were least advantaged.  For the Equinet group, the provision of 
ART on a large scale was a major opportunity to strengthen weak and dysfunctional health 
systems.  It was also a chance to try to address and resolve entrenched inequities in many 
southern African settings in terms of which individuals and groups, based on social and 
economic condition, had ready access to health care services and which had little or none.  The 
expectations of ART programs were large indeed in terms of addressing much broader, systemic 
health challenges.   
 
When taken together, all of the commentators suggested that (procedural) fairness and 
(substantive) equity should be the measures of success in providing ART in resource-limited 
settings.  They further suggested that the following characteristics of the patient selection process 
(over and above issues of eligibility), where they were apparent, had the greatest potential to 
achieve these outcomes: 
 
 The existence of formal, explicit eligibility criteria developed through a structured, inclusive 
and transparent process of deliberation; and, 
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 The existence of a structured, inclusive, transparent and publicly accessible process for 
applying the criteria and for deliberating on exceptions. 
 
How have health care teams who work at the front-line of ART program delivery fared in terms 
of this advice?  Have the proposed relationships between patient selection processes, fairness and 
equity been absorbed and implemented in these settings?  The limited evidence that is emerging 
in the literature regarding the experience of health care teams suggests that it has not.   
 
Recently, an example of this was provided in a published case study of a Médecins-sans-
frontières-sponsored treatment project in Khayelitsha, South Africa (Fox & Goemaere 2006).  
The study, when published, was accompanied by ethical reflections written by Macklin (2006) 
and Solomon Benatar (2006).  The two authors were sensitive to the struggles of the treatment 
teams to develop and maintain patient selection processes that achieved fair distribution of their 
service to a maximum number of individuals in need.  The Khayelitsha team adopted a ‘first-
come-first-served’ approach using clinical and social criteria to evaluate patients’ eligibility for 
ART.   Committees were established at each treatment site to determine patients’ eligibility; 
however, few if any patients were deemed not eligible, they were simply given more time and 
assistance to meet the eligibility criteria:  “We never definitively give a ‘no’…We just say, ‘not 
ready.’” (Fox & Goemaere 2006: 306).  There was extreme reluctance on the part of the team to 
enter into more direct forms of selection and more explicit approaches to rationing.  It was felt 
that doing this struck at the core of important values and beliefs about the provision of ART and 
the appropriate role of the treatment team (Benatar 2006: 326).   
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Aside from the Khayelitsha study, there have been few other published accounts of how ART 
programs have addressed patient selection and the need to ration.  The literature is predominantly 
normative or speculative, with little reference to how rationing or targeting has been carried out 
(see, for example, McGough et al., 2005; Wilson, Blower, 2005; Capron, Reis, 2005).  There are 
many common features to the advice that has been given, including the need to establish clear 
goals in distribution strategies, the need for them to reflect sound legal and ethical approaches, 
the advantages and challenges of prioritizing certain groups, the need to achieve equitable and 
fair distribution outcomes and, finally, the need to use broadly inclusive, deliberative processes 
in the development of rationing strategies.   
 
In one of the few articles to document actual experience, Muula (2004) described ethical and 
programmatic challenges in Malawi where, although 150,000 individuals were estimated to need 
antiretroviral therapy in 2004, only between 25,000 and 50,000 were to receive it over a five-
year roll-out period.  While the National AIDS Commission did organize a broad, deliberative 
process to discuss eligibility criteria and priority groups, ultimately a first-come-first-served 
approach was chosen mainly because no consensus could be reached on which groups should be 
treated first.  A GTZ-sponsored case study in Tanzania (WHO 2006c) documented the decision-
making process in the development of that country’s national ART program.  Although 
determining priority groups for access to treatment was discussed in the process, no prioritization 
decisions were made.  Clinical and social eligibility criteria were created that would be applied to 
all individuals who gained access to the program.  Finally, Rennie et al. (2006) gathered 
preliminary data on attitudes to the selection of patients for ART in a small community in the 
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Democratic Republic of Congo.  Their work showed the potential for discrimination and 
exclusion where attempts to prioritize groups or individuals are made in the absence of an 
informed, deliberative process to develop selection criteria.  In this situation, socially 
marginalized or ‘different’ groups and those considered to have ‘caused’ their HIV infection 
were identified as those to be denied preferential access to ART.   
 
Study Purpose 
 
Overall, it would appear that there are variations in how ART programs have evolved and how 
they have confronted the challenge of who should be treated now and who should continue to 
wait.  In many respects, this very direct issue has been addressed only indirectly.  The approach 
favoured in the few programs where experience has been documented is to treat all those who 
gain access to ART programs and who meet eligibility criteria.  There is no process of explicit or 
active patient selection and there is an extreme reluctance at the different levels of program 
development and implementation to engage in this.  Why does the first-come-first-served 
approach predominate and does this mean that ART programs are unfair or inequitable?  The 
purpose of the study was to examine this question using the experience of a health care team 
working at an ART site in rural Lesotho.  It was further to assess whether or not the concepts of 
fairness and equity had relevance or operative value for the treatment team.   Finally, the study 
had a practical aim which was to provide a reflective learning opportunity.  Study results were 
shared with the treatment team and their observations are included in the study findings.  These 
in turn led to action-oriented recommendations to help guide process improvement and further 
reflection on the ethical challenges raised by patient selection. 
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Method 
 
The study followed an exploratory case study design (Yin 1994:  38-44).  It occurred at St. 
Charles Mission Hospital, Seboche, Lesotho.  The hospital serves a rural population of 
approximately 40,000.  It provides ART through its outpatient department as part of a 
collaborative project with the Government of Lesotho and as Swiss-based international 
development organization called SolidarMed.  The site was chosen largely because it is 
representative of the setting where most local ART programs operate in Lesotho (i.e. outside of 
urban settings where the population is impoverished and geographically disbursed across 
extremely difficult terrain).  The period of analysis was from program inception in 2005 to the 
most recent, available data in 2007.   
 
There were two components to the method structure:  a qualitative component to document and 
assess the selection process and to examine the relevance of concepts of fairness and equity 
within the treatment team; and, a quantitative component to measure substantive equity.  Data for 
the study was collected through semi-structure interviews of key informants, document reviews, 
direct observation, and the abstraction of aggregate, anonymized data on patient characteristics 
from monthly progress reports and treatment registers.  Fifteen key informants were interviewed 
during two field visits (4 doctors, 1 nurse clinician, 2 nurses, 3 HIV counsellors, 1 peer educator, 
2 pharmacy technicians and 2 administrators).  All those approached for interview agreed to 
participate.  Two individuals originally identified as informants were not available either during 
the first or the follow up visits.      
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The qualitative data analysis process followed procedures suggested by Yin (1994: 110) and 
Miles and Huberman (1994: 85) for building explanations of phenomena based on interviews 
and document reviews.  This involved isolating and coding data segments, arranging them into 
thematic groups and then using an iterative process of combining and distilling the segments to 
come up with concise, robust explanations of what was observed.  Equity was examined using a 
quantitative approach.2  A χ2 analysis of key characteristics (data was only available on age and 
sex) of the population receiving treatment against those in need of treatment was performed, 
including a comparison involved comparison these groups against the general population living 
around St. Charles.  This statistical test for independence would show, for example, if certain 
groups were overrepresented in either the general population or the HIV-positive population and 
under-represented in the treatment population without a justification. 
 
This study was approved by the Health Research Ethics Committee of the Faculty of Health 
Sciences, University of the Witwatersrand.  It was also approved by the Research Ethics 
Committee of the Ministry of Health and Social Welfare, Government of Lesotho.  Finally, the 
study was approved by the Medical Superintendent of St. Charles Mission Hospital on behalf of 
the board and the administration of the facility (see Appendix B for clearance certificates).  
 
                                                          
2 This aspect of the study followed an approach suggested by Kalanda et al. (2004: 18-19) at Equinet. 
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Findings 
 
a)  Setting the Stage:  Patient Selection for ART at St. Charles Hospital  
 
To situate the analysis of fairness and equity in relation to patient selection at St. Charles 
Hospital, it is first necessary to briefly describe the selection process itself.  Currently, ART is 
provided at St. Charles in the Outpatient Department (OPD) along with other health care 
services.  Figure 1 below shows the main stages an individual passes through in gaining access to 
ART: 
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Individuals enter the ART program at St. Charles in a variety of ways.  A clinical finding of 
HIV-disease, in the form of a documented HIV-positive test result, is the first step.   Once an 
individual is determined to be HIV-positive, an eligibility assessment is performed on both 
Individual comes to St. 
Charles seeking HIV test. 
Individual comes to St. 
Charles seeking medical care 
and is referred by nurse or 
doctor for HIV test. 
Individual comes to St. 
Charles with HIV-positive 
result.  
HIV testing.  If HIV-positive, 
sent to laboratory for CD4. 
Clinical assessment.  
Application of clinical 
eligibility criteria.  If eligible, 
referred for adherence 
counselling 
Adherence counselling.  Three 
sessions (two if pregnant). 
Readiness Assessment (same 
time as last adherence 
counselling session.). 
Return to doctor for first 
prescription and willingness 
assessment. 
Collection of ARVs from 
dispensary.  Further 
‘readiness’ assessment. 
CD4 test.  Other laboratory 
diagnostics if required. 
If not ‘ready’, repeat 
adherence counselling. 
If not ‘willing’, refer back to 
adherence counselling. 
If not ‘ready’, issue 
medications but refer back to 
adherence counselling. 
Figure 1: Patient Selection for ART at St. Charles 
H i l
 
Clinical eligibility 
assessment 
 
Non-clinical eligibility 
assessment 
Ready? 
Willing? 
START 
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clinical and social grounds.   The eligibility criteria originate from different sources, including 
guidelines published by WHO in 2004 and revised in 2006 (WHO 2006); national ART 
treatment guidelines for Lesotho (GoL 2004); practices based on the WHO’s Integrated 
Management of Adult and Adolescent Illness (IMAI) program (WHO 2004b; WHO 2006b); and 
practices based on what the team at St. Charles understands the national approach to be even 
when the source of such understanding cannot be fully substantiated (sometimes it is simply a 
verbal direction given during a supervisory visit by the national consultant in charge of 
monitoring the ART program).  There is not one, overall document either at St. Charles or 
nationally that sets out all of the eligibility criteria.   
 
The clinical eligibility criteria for ART are as follows: 
 
Table 1:  Clinical eligibility criteria 
 
Criteria Sources 
Adults  
 clinical finding that the patient is HIV+ 
documented in the bukana 
National ART guidelines (GoL 2004) 
WHO guidelines (WHO 2006a) 
IMAI Chronic Care Module (WHO 2006b) 
 
 
 WHO stage IV, any CD4 
 WHO stage III, consider treatment if CD4 < 350 
 CD4 < 200, any WHO stage 
 do not start ART if: WHO stage I and II and 
CD > 200 
 not active TB (ART initiation is delayed for two 
weeks if the patient is CD4 <200) 
Pregnant women  
 if CD4<350, initiate ARV treatment as soon as 
possible 
Revised national PMTCT guidelines (GoL 2007c) 
For Children  <15 years  
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When to start ART (according to revised WHO 
guidelines 2005): 
 
 depending on: 
CD4 % and/or CD 4 count  
 
< 11 months: < 25 %  < 1500 
12-35 months < 20 %  < 750 
36–59 months < 15 %  < 350 
>= 5 years < 15 %  < 200 
  
 and/or clinical stage IV; 
 in clinical stage III: doctors decision considering 
stage, CD4% and clinical appearance 
National ART guidelines (GoL 2004) 
WHO guidelines (WHO 2006a) 
IMAI Chronic Care Module (WHO 2006b) 
 
 
 
 
 
These are based on the WHO approach to prioritizing access to ART.  The requirement in adults 
for a CD4 count of <200, for example, selects only the sickest of those who might otherwise be 
able to benefit from ART.   Individuals with CD4 counts between 200 and 350 might benefit 
from treatment but offering it to them would overwhelm the national ART program according to 
the national guidelines (GoL 2004: 18).3   For pregnant women, initiation of ART on an urgent 
basis prevents against transmission of HIV to newly born children during labour and delivery by 
suppressing viral load.  For children, the decision to initiate ART is more complex depending on 
the age of the child, the stage of immune system breakdown as a result of HIV-infection and 
where or not other symptoms of advancing HIV-disease are present. 
 
If the patient meets the clinical eligibility criteria for ART, the patient is referred to the ART 
                                                          
3New national treatment guidelines for Lesotho, which are still in draft form, raise the CD4 eligibility requirement to 
350 copies/ml2 (GoL 2007b:  34).  While this allows more individuals the potential to access ART, there has been 
no corresponding adjustment to the capacity of treatment programs or, more controversially, no guidance in terms of 
whether very sick individuals with little chance of sustained benefit of ART should no longer gain access to 
treatment programs.  Admittedly, such a determination is an extremely difficult one to make. 
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Nurse or the HIV/AIDS Coordinator for an assessment against non-clinical eligibility criteria.   
These relate primarily to the question of adherence, specifically prospective adherence.  They are 
meant, ostensibly, to both prepare and select those patients most likely to adhere to treatment 
regimens.  Adherence primarily means taking ARV treatment at specific times daily for the rest 
of the patient’s life even though it may cause significant side effects.  Adherence also means 
attending ART clinics or health centres on a regular basis for routine clinical monitoring and for 
refills of medications.  At St. Charles, the non-clinical eligibility criteria are as follows: 
 
Table 2:  Non-clinical eligibility criteria 
Criteria Source(s) 
 the patient has disclosed his/her status 
 
National guidelines (GoL 2004) 
IMAI Chronic Care Module (WHO 2006b) 
IMAI Participant Manual (WHO 2004b) 
 the patient has identified a treatment supporter 
(treatment supporter to come to 2nd and 3rd 
sessions) 
National guidelines  
IMAI Chronic Care Module  
IMAI Participant Manual 
 the patient has attended 3 adherence counselling 
sessions (first two at Seboche or at nearest health 
centre; last session at Seboche with either ART 
nurse or ART coordinator) 
IMAI Participant Manual 
IMAI Chronic Care Module  
Site-specific practice (particularly last session with 
ART Nurse or HIV/AIDS Coordinator) 
 the patient is READY to start ART (understands 
the content of the adherence counselling sessions, 
i.e. patient can answer most of nine ‘Adherence 
Check List’ questions correctly; cleared by ART 
nurse or ART coordinator) 
National guidelines 
IMAI Chronic Care Module 
IMAI Participant Manual 
 
 the patient is WILLING to start ART (patient 
gives informed consent) 
National guidelines  
 
 patient has capacity (there is no substitute 
decision-making practice except in the case of 
minors) 
Standard clinical practice (not documented) 
 
 
Patients must attend a minimum of three adherence preparation sessions where they learn in 
detail what ART is and what commencing such treatment involves.  During the last adherence 
session, the patient’s readiness, or his or her knowledge of ART and the implications of starting 
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treatment, is assessed by either the ART Nurse or the HIV/AIDS Coordinator.  If the patient 
successfully completes the readiness assessment, he or she then returns to the doctor to be given 
the first ART script.  If the patient is not successful, more adherence preparation sessions are 
scheduled.  During the consultation with the doctor, the doctor may also do a readiness 
assessment and will determine ‘willingness’ or the degree to which the patient actively consents 
to start ART (rather than simply deferring to the recommendation of the doctor, as one key 
informant explained).  If the patient is not ready according to the doctor, then he or she will be 
referred for more adherence preparation sessions.   
 
There are inconsistencies between what is stated in the source documents for some of the non-
clinical eligibility criteria and what is practiced at St. Charles.  The requirement that a patient 
attend three adherence preparation sessions is one such example.  The national guidelines and the 
IMAI training tools suggest that multiple sessions may be required but do not stipulate a specific 
number (GoL 2004: 9; WHO 2004b: 71; WHO 2006b: H44).  Similarly, with regard to requiring 
disclosure and identifying a treatment supporter, these are recommendations for improving 
adherence in the national guidelines and the WHO materials (GoL 2004: 9; WHO 2004b:  29; 
WHO 2006a:  70-71).  They are not requirements.  There is one other condition that an 
individual must meet to be selected for ART.  He or she must be mentally competent.  Patients 
who are too weak or mentally confused (as a result of complications of advanced HIV disease, 
for example) may not be counselled or tested.  In addition, if they are HIV-positive, adherence 
counselling may not be done and the patient not started on ART.   
 
Some selection criteria have exceptions; others do not.  In a selection process, the purpose of 
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exceptions is to recognize special circumstances and enable access to treatment in these cases 
where individuals might otherwise be ineligible for ART.   The exceptions to eligibility criteria 
are detailed below: 
 
Table 3:  Exceptions to eligibility criteria 
 
Criteria Exception 
HIV+ test result There are no exceptions. 
WHO Stage/CD4  There are no exceptions. 
Disclosure Patients can be started on ART if they are reluctant to disclose but 
meet other criteria, in particular having attended adherence 
counselling and being assessed as ready and willing to start ART. 
Treatment supporter Not having identified a treatment supporter is related to reluctance to 
disclose.  If patient meets other criteria then he/she can start 
treatment. 
Adherence Counselling Pregnant women can be initiated after two sessions if they meet the 
ready and willing criteria. 
Ready to start ART Pregnant women can be ‘ready’ after only two sessions. 
Willing to start ART No exceptions. 
Capacity Parents or guardians can request testing and consent to treatment for 
minors.  Must be authorized by an MD. Otherwise, no exceptions. 
 
 
A finding of being HIV-positive is required before ART can be prescribed.  However, if a patient 
is unable to give consent to be tested and to participate in pre-test counselling, this particular 
aspect of the diagnosis cannot be made.  Doctors may or may not have the ability to test in the 
absence of consent in order to initiate treatment in life-threatening circumstance (an official 
change to Lesotho’s HIV testing policy has not yet been formally communicated).  New 
treatment guidelines for Lesotho propose a substitute decision-making mechanism that allows 
hospital authorities to give provisional consent for the initiation of treatment.  Such provisional 
consent lasts until the patient regains capacity to make his or her own decision whether or not to 
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continue treatment.4  On the requirement for disclosure and for a treatment supporter, 
discretionary room is limited.  Some individuals are able to begin ART without having disclosed 
their status or identifying a treatment supporter.  It was not clear from the key informants on 
what basis such an exception was granted other than the persuasiveness of the particular patients 
to argue that either disclosing or identifying a treatment supporter was impossible to do.  What is 
clear is that exceptions to eligibility criteria are limited.  None appear to have emerged from a 
lengthy deliberative process.  Most have been adopted by the ART team as a result of either 
training curricula or specific statements in national or international guidelines.  There is no 
formal process of deliberation on exceptions.  Individual team members confer with each other.  
There are no group discussions of specific patient issues.   
 
 
b)  Issues Arising from the Patient Selection Process 
 
At the moment at St. Charles, patient selection for ART follows eligibility criteria that are 
largely externally imposed through the national ART program.  There has been no inclusive, 
deliberative process at the site to adopt these criteria.  Nor is there a formal process of patient 
selection.  Some individuals or groups gain access to ART without meeting all of the eligibility 
criteria.  Not all eligibility criteria have an empirical basis and some may be unduly onerous for 
some patients.  What does this mean for patient selection in terms of fairness and equity?  A 
selection process will be fair or equitable to the extent that it relies on a principle or goal that can 
be justified in relation to those who are affected by the rationing problem.  The goal must be 
explicit in terms of who is to be given priority in the selection process and why these individuals 
or groups should be preferred over others.   
                                                          
4Personal communication, Dr. Roland Dürig. 
 
 
 
 
 
 
22
According to Lesotho’s national treatment guidelines and the WHO-developed training program 
that supports them, the goal of the ART provision at St. Charles and elsewhere is to put as many 
of the ‘right’ or eligible people on treatment as possible (WHO 2006b: H26): 
 
“Remember:  ARV therapy for the individual is rarely an emergency!  The public health 
emergency is to get large numbers of the right patients on treatment with good adherence 
and good overall HIV chronic care. For the individual patient, management of life-
threatening opportunistic infections can be an emergency.”   
 
Here the principle is explicitly utilitarian in that it aims to provide treatment to the greatest 
number of those who will derive the most benefit.  This means selecting those whose clinical 
condition allows for maximum clinical improvement (not too sick, not too well) and those whose 
social circumstances are conducive to adherence (taking the treatment correctly for as long a 
period of time as possible).   
 
If there are ‘right’ people for treatment, then there are those who are ineligible for treatment.  In 
this latter group are, presumably, those whose clinical condition does not yet warrant ART (to 
the extent that they would experience significant greater benefit over those who are less well) or 
whose social condition or personal motivation are not conducive to successful adherence.  This 
group may also include the very sick whose clinical condition has deteriorated to such an extent 
that ART will provide little if any sustained benefit.  The goal is very indirect in this respect.  As 
patient selection was observed at St. Charles, an incompletely realized approached to the 
utilitarian goal emerged.  While there was alignment with the need to put as many individuals on 
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treatment as possible there was reluctance to explicitly deny anyone treatment and the team made 
extended efforts to assist some individuals to meet all of the eligibility criteria (or to grant 
exceptions).  It raised the question of whether more individuals could have been initiated on 
treatment if less time and effort was expended with some patients to assist them to meet the 
eligibility criteria.  Was fairness emphasized at the expense of equity, perhaps, or vice versa?  
Can this utilitarian approach effectively guide treatment teams in the absence of greater clarity 
and direction on who should be denied treatment and what ART programs in these settings 
should strive to achieve? 
 
 
c)  Fairness 
 
 
Daniels (2004: i) has proposed that in situations where benefits are limited and need is greater 
than supply, fairness can only occur in the form of fair process.  Fairness as an outcome cannot 
be achieved when some are denied benefits for the sake of others.  The situation in Lesotho, 
where need for ART exceeds the capacity to provide it, is fundamentally unfair.  Certain 
individuals receive treatment while others do not.  Fairness was explored in the interviews using 
a simple open-ended question: “Do you think the [ART patient selection] process is fair?”  
Informants viewed fairness as both an absence of (moral) judgement and the consistent 
application of the national guidelines as they are understood by the treatment team.  According to 
one informant: 
 
“I didn’t judge that person.  I treated that person like every other client.  I didn’t do any 
favour.  I didn’t impinge upon his or her right.  I just did what was agreed upon....We are 
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not only making our decisions.  We are following the guidelines.” 
 
In the words of another:  “I try to treat everyone the same.  I just sit in my office.  I just see the 
people I see.”    Fairness also means that no patients are refused:  “We don’t refuse 
anybody...Anyone who needs help from us, they get it.  We don’t pick and choose.”  When a 
patient does not proceed through the steps towards gaining access to ART, it is not because they 
were not selected for treatment.  It is because the eligibility criteria were not met, a situation that 
is the responsibility of the patient.  To the extent that there is patient selection, it is implicit.  
Where selection occurs, it is viewed by the team as self-selection, meaning that patients self-
select not to continue with the process of meeting eligibility criteria for reasons that are beyond 
the team’s control.  
 
While the treatment team perceives that it impartially administers a set of well-defined eligibility 
criteria, between perception and practice, there are some challenges at St. Charles in terms of 
fairness.  Procedural fairness requires decision criteria that have a definable relationship to an 
overall goal and, upon analysis, not all criteria used at St. Charles are clearly connected to 
providing ART to the greatest number of patients who will derive the most benefit.  The 
requirement that an individual disclose his or her HIV status to someone else and provide proof 
of disclosure is a very significant one, particularly within a rural context where stigma against 
HIV-disease predominates.  Similarly, the requirement that individuals also seek out a treatment 
supporter may be equally burdensome.  As Macklin (2006: 316-317) has noted, requiring 
disclosure infringes on individual privacy and insisting on a treatment supporter limits 
autonomy.  Limiting privacy and autonomy requires careful justification in terms of the 
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effectiveness of such limits on improving the benefit of ART.  Despite statements in WHO 
training materials and in Lesotho’s national guidelines assuring health care providers that such 
things lead to better adherence, there exists little empirical evidence to support these criteria as 
improving the efficacy of treatment.5  Given repeated counselling sessions and other tactics that 
are used with patients in order to persuade them to disclose their status or to locate a treatment 
supporter, and given the fact that some who do not disclose or cannot locate a treatment 
supporter are not started on ART, the rationale for the application of these criteria becomes 
questionable.  One must ask what is the value of these efforts if, in the end, the effect on patient 
adherence is not measurable.   
 
Within the patient selection process, those who lack capacity, including those who are very sick 
or have other mental capacity challenges, are more likely than others not to receive ART.  For 
the very sick, some team members would like to initiate ART immediately as this would improve 
a patient’s condition to the point where the capacity issue would resolve.  Others, either 
explicitly or implicitly, feel that the very sick will die anyway and that the efforts of the team 
should be directed at those who are likely to have better, longer term improvement from ART.  
There is evidence to show that starting the very sick immediately on treatment does not lead to 
better outcomes.  The number that improves and survives is very small in comparison to the 
number that die within a short period following initiation of treatment.6  Unfortunately, for the 
                                                          
5   In the study by Mills et al. (2006:  2055) there was evidence in developed world settings that disclosure within a 
supportive social network improved adherence.  No such evidence was found in developing world settings largely 
because the issue had never been explored.  In the ARV treatment guidelines of 2006, the WHO comes to a similar 
conclusion (WHO 2006a: 70). 
6   See, for example, the study by Rosen et al. (2007).  Across the many cohorts examined in this systematic review, 
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treatment team at St. Charles, there is little guidance for them in terms of how to resolve this 
dilemma.  The Lesotho treatment guidelines and the WHO standards are silent on when 
treatment should no longer be considered.  As one informant noted: 
 
“The guidelines help me to do the decision.  But what I think is difficult is that we cannot 
start patients without all these counselling sessions...The patients in bad condition, we 
lose them.”  
 
The absence of more explicit decision rules regarding the very sick causes challenges for the 
treatment team at St. Charles.  While the effect of the eligibility criteria is to deny ART to this 
group, it achieves this indirectly.    
 
The idea of fairness as a structured, formalized selection process which includes the ability to 
make carefully justified exceptions does not figure in the approach to ART provision at St. 
Charles.  The differing views on whether or not it is fair to not initiate ART for the very sick 
highlights the reluctance of the team as a whole to face patient selection more directly.  For 
them, fairness is non-discrimination in any direct sense and the equal opportunity patients have, 
once they enter the ART program at St. Charles, to meet eligibility requirements.    Selection 
occurs as a result of externalities not as a result of deliberate decisions by the team to choose one 
individual or group of patients over another.   
 
                                                                                                                                                                                           
late entry into treatment programs (i.e. low CD4 counts) was consistently associated with early death. 
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d)  Equity 
 
Fairness as correct procedure requires a counter weight to ensure that individuals or groups are 
not denied access to treatment for avoidable or irrelevant reasons that may arise not only from 
the decision rules themselves but from the larger context in which the selection process operates 
(McCoy 2003: 11).  Equity in rationing problems links (procedural) fairness to outcomes.  At St. 
Charles, for example, individuals may not be able to receive ART not because they are not 
eligible but because they cannot travel to the hospital to enter the program.  Equity is a measure 
of what efforts are made to overcome such barriers or exclusions.  It was explored in two ways in 
the study:  through the key informant interviews and through an analysis of operational data.  In 
the interviews, the researcher explained equity as all individuals having equal chances to receive 
treatment suggesting that where there were barriers or challenges, efforts were made to address 
these inequities.  For some informants, the opportunity to access treatment was the same for all.  
What hindered access to treatment were individual barriers that could not be resolved by the 
treatment team:  “We don’t hinder anyone.  The clients hinder themselves.” 
 
Other members of the treatment team had different views.  Issues of poverty and distance prevent 
some from accessing treatment.  According to one informant, “Some people don’t get treatment 
because they are too far.”  She suspects that the sick, neglected, or very poor, do not return to the 
clinic once they are seen initially.  “I can imagine they won’t come back.  They are badly dressed 
or the translator says they won’t come back.”  However, this happens for all services provided by 
St. Charles, not just ART.  In the words of another informant:  
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“The more you know, the closer you are, you are more likely to come for service.  I’m 
not sure.  But it’s not only for ARVs, it is for everything.” 
 
According to still another, there are insurmountable challenges in the way of achieving equity, 
including geography, infrastructure and lack of staff:  “We are not marginalizing. We are forced 
by circumstances.”  One informant felt that individuals should not all have the same chances and 
that there should be priorities:   “I don’t think everyone should have the same chance.  I am more 
reluctant to put older people on treatment unless they are care takers.”  For this informant, 
younger people, children and mothers are priorities.   “We have to do a triage....I don’t tell them 
[older patients] I won’t put you on treatment.  I just don’t insist.”   
 
Accordingly, there is a range of interpretations of equity within the treatment team.  There is 
knowledge amongst some that social, economic or geographic conditions inhibit individuals and 
groups from gaining access to ART and that this is inequitable.  The ART program at St. Charles 
does make efforts to address these.  It provides reimbursement for transport costs for those 
patients with this difficulty.  The hospital works with patients who have no funds to make 
arrangements for payment (this can include bartering food, livestock or some other possession of 
value in exchange for exemption from cash payment).  A limited amount of food aid is provided 
through the primary health outreach program.  The outreach team conducts regular visits across 
the region and integrates HIV testing and counselling and patient follow-up within these more 
general efforts.  The hospital is in the process of implementing decentralization of ART, meaning 
that it is attempting to make it available at local health centres across the region rather than 
exclusively through the hospital’s OPD.  At the moment, adherence preparation sessions take 
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place at health centres; HIV testing and counselling is available at all health centres, and one 
health centre is beginning to provide ART. 
 
As for the many other individual and environmental factors that inhibit access to treatment (and 
health care generally), there is less ability on the part of the team to address them.  Stigma in a 
range of forms is deeply entrenched in the communities around St. Charles.  Traditional beliefs, 
coupled with poverty and literacy challenges, also impede the extent to which the treatment team 
can provide services across the area.  These constraints raise much larger issues beyond one 
health service area and one treatment program.  They occur all across the southern African 
region.  They raise much more complex issues of equity and fairness.   
 
There is no doubt that the treatment team does its best to address stigma, fear and general 
reluctance on the part of patients to either test for HIV or to start ART.  Messages are repeated, 
individuals are re-counselled, some are found in their villages and homes for more persuasion to 
seek help.  Attachments to traditional beliefs are part of world views that orient individuals to 
their surroundings and help to sustain them in times of adversity and change.  Accepting the 
decisions that result from these is part of respecting patient autonomy as crushing as it may be 
for health care providers to see individuals deny themselves the benefit of ART.  ART is 
inaccessible to the very sick and the very poor who cannot overcome the barriers of inadequate 
food, no transportation other than walking, and roads and footpaths that may be inaccessible due 
to weather conditions.  The efforts of the treatment team to reach all in need are blocked by 
broader health system challenges in Lesotho.  There is little at their level that they can do to try 
to mediate this broad network of constraints that create inequity. 
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What does the operational data suggest in terms of the efforts to address inequities and to 
improve access to ART across the Seboche region?  Table 4 shows estimated and actual values 
for the population surrounding St. Charles Hospital and those seeking HIV counselling, testing 
and initiation on ART.  There are some variances between what is recorded by the St. Charles 
team and both the age and sex distribution for the population area, and the estimated differences 
in HIV prevalence amongst these groups.  The proportions of those seeking HIV testing in the 
Seboche area are 75% women, 19% men and 5% children (vs 30%, 29.6% and 40.4% according 
to the estimated age/sex distribution).  Those seeking testing are overwhelmingly adult women.  
Of the males in the population who seek out HIV testing, a much larger proportion are HIV-
positive (36% vs 18.7%) than what is estimated nationally in Lesotho.   Of those who present for 
testing and are found to be HIV-positive, they are also overwhelmingly women.  67% of HIV-
positive individuals are women as compared to 29% men and 4% children.   
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Table 4:  HIV testing and ART provision for 2006/2007 
 
 A B C D 
 
E F G H I  J  K 
 Populati
on by 
Age and 
Sex 
%of 
Total 
%HIV+ 
(Estimat
e) 
Estimate
d HIV+ 
(A*C)   
Seeking 
HIV 
testinge 
% of 
Total 
HIV+e %HIV+ % of 
Total 
Started 
on ARTf 
% of 
Total 
Adult 
Males 
11264a 29.6% 18.7%c 2106 554 19% 199 36% 29% 119 26% 
Adult 
Females 
11492a 30% 24.3%c 2793 2166 75% 464 21% 67% 301 65% 
Children 
(<15 yrs) 
15426a 40.4% 6%d 919 158 5% 29 18% 4% 42 9% 
TOTAL 38182b 100% NA 5873 2878 100% 692 24% 100% 462 100% 
 
aOf the total population in Lesotho, it is estimated that 40.4% are under the age of 15 (UNDP 2007) [.404*38,183=15,426].  For the adult population, 49.5% are 
male (GoL 2007b) [.495*(38,182-15,426)=11,264]. 
bEstimated population for the Seboche area, combining the constituencies of Mechachane and Hololo (GoL 2007b). 
cGoL 2005: 37. 
dGoL 2008: 5 
eData from operational reports covering January to December, 2007 
fData from operational reports covering May 2005 to December 2007 
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There are other findings of note when comparisons are made using other indicators of HIV-
disease burden and need for ART.  Table 5 shows estimated need for ART in the Seboche area 
compared to those currently receiving treatment. 
Table 5:  Estimated need for ART and actual coverage 
 A B 
(.15*A) 
C 
(.15*A) 
D E 
[(D/B)*100] 
F 
[(D/C)*100] 
 Estimated 
HIV+ 
Estimated 
Need for 
ART Low 
(15%)a 
Estimated 
Need for 
ART High 
(19%)a 
On ART 
at Dec 
2007b 
%Coverage 
Low 
 
% Coverage 
High 
Males 2106 316 400 119 38% 30% 
Females 2793 419 531 301 72% 57% 
Children 
(<15 yrs) 
919 138 175 42 30% 24% 
TOTAL 5873 873 1105 462 53% 42%% 
 
aThe WHO estimates that, at any one time, 15% to 19% of the HIV-positive population is in immediate need of ART 
(WHO 2005).7   
bData from operational reports covering May 2005 to December 2007 
 
 
Comparing the estimated need of ART with the number of those initiated on ART at St. Charles, 
one could conclude that the program has reached between 41% and 53% of the overall 
immediate need for treatment.  For men the range is 30% to 38%; for children the range is 24% 
to 30%.8  These estimates are broad and speculative.  To the extent that they reflect the nature of 
need for treatment and the efforts of the treatment team at St. Charles to address it, they suggest 
much greater equity challenges in that for these groups, the majority of those in need do not yet 
obtain ART.     
 
To test the independence of these variances, a χ2 analysis was performed using the observed and 
                                                          
7This model uses CD4 lymphocyte count of <200 cells/ml2 as one of the criteria to estimate need.  Under new 
eligibility criteria (CD4 count of  <350 cells/ml2) the number of individuals in need of treatment would be greater. 
8 Estimates of HIV prevalence, need for ART and coverage of ART for children <15yrs have been difficult to obtain 
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expected values set out in Table 6 below.  The results were significant [rejection region:  χ2 ≥ 
14.8602  df=4  p=.005; χ2=3130.882].  The analysis confirms what was noted above, that adult 
males and children of both sexes are significantly under-represent amongst those seeking HIV 
testing and those estimated to be in need of ART in the geographic region service by St. Charles 
Hospital.   None of these patterns are unique to St. Charles; they reflect what has been observed 
across the southern African region.  They are the result of the complex interplay of social, 
economic and cultural factors.  In the rural areas of Lesotho, men must travel far to seek work 
while women remain in their villages to care for families.  Culturally, illness generally, and HIV 
disease in particular, are stigmatized among males, particularly in rural environments where the 
traditional attitudes and beliefs about men’s roles still predominate.  Lesotho, overall, has very 
poor child health indicators with very high rates of mortality, even in comparison to other 
countries at similar stages of development (UNDP 2007).  It is not surprising, then, to see this 
reflected in the absence of children amongst those seeking HIV testing and treatment.    
 
 
                                                                                                                                                                                           
for Lesotho.  Recently, it was estimated that the ART coverage was 26% nationally for this group (GoL 2007a: 53).  
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Table 6:  Observed and expected values for uptake of HIV testing and ART 
A B C D E F G H I J K L 
Sex/Age Population %Total Observed 
Seeking 
Testing 
Expected 
Seeking 
Testing 
Estimated 
HIV+% 
Observed 
HIV+ 
Expected 
HIV+ 
(E*F) 
Estimated 
Need for 
ART (at 
15%) 
%Total Observed
ART 
Expected 
ART (at 
15%) 
Male 11,264 30% 554 863 18.7% 199 104 316 36% 119 167 
Female 11,492 30% 2166 863 23.4% 464 537 419 48% 301 222 
Child 
(<15yrs) 
15,426 40% 158 1151 6% 29 9 138 16% 42 73 
Total 38,182 100% 2878 2878  692 692 873 100% 462 462 
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Discussion 
 
 
a)  The Ethics of Patient Selection 
 
What light can fairness and equity shed, then, on the ethics of patient selection at St. Charles?  
As for fairness, the treatment team applies eligibility criteria that are national and internationally 
determined on a first-come-first-served basis in what it perceives to be an open and non-
discriminatory fashion. As for equity, there are some efforts to address barriers of poverty or 
distance, for example, for some groups.  For others, such as the absence of men from the 
treatment program, the team feels somewhat powerless.  There is no overall strategy to target or 
prioritize segments of the community around the treatment site.  There is no evidence of any 
discussion in terms of which groups in the community should gain immediate access to treatment 
and which groups should continue to wait, beyond what the eligibility criteria determine in terms 
of minimum CD4 lymphocyte counts.  The advice of Macklin and Daniels, quoted earlier, 
appears to have gone unheeded and, in fact, there is some reluctance to consider such questions.  
The team believes its role to be to administer externally determined eligibility criteria and not to 
engage in any more direct process of rationing or prioritization.  For the team, a first-come-first 
served approached is the only morally acceptable one to the situation it finds itself in.  It believes 
that it is doing the best it can in terms of the overall national goal of offering ART to as many 
eligible individuals as possible.  What prevents more adults and children for coming forward for 
treatment are largely things beyond what the treatment team can influence.   
 
Why is there this reluctance to consider the larger questions of fairness and equity?  It may be 
that staying within such an externally imposed structure, even when it may appear to have 
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inconsistencies, is a very pragmatic approach for a team faced with a difficult task.  Too many 
exceptions or too much deliberation put a burden on the treatment team that may impede the 
efficiency of the program or make it inoperable.  A more explicit patient selection process may 
also be morally burdensome to such an extent that team members would refuse to participate.  At 
the moment, given the lack of adequate data, it is impossible to know the extent to which 
individuals may be denied access to treatment because of the selection process.  As the ART 
program operates now, many have an opportunity to start ART, many take that opportunity and 
many succeed.  What puts all of this in perspective, however, is the fact that most of those who 
need treatment do not yet receive it and this much greater challenge to fairness and equity goes 
far beyond the local efforts of the team at St. Charles.   
 
It is clear that the architecture of criteria and selection processes aimed at achieving fairness and 
equity have not informed the St. Charles treatment program.  Is it the absence of this that is 
contributing to the extraordinary gap between those on treatment and those in need or is it 
something else?  Rather than highlight challenges and opportunities in the work at St. Charles, 
perhaps the ethical analysis should point to much larger limitations in the overall approach to 
ART provision in such circumstances.  This is not a criticism of the team at St. Charles or its 
tremendous efforts.  Rather, it is a challenge to the global effort to provide ART in resource-
limited settings which, as McCoy et al. (2005: 20) warned, was fraught with pitfalls and would 
not result in an equitable distribution of ART.  The pitfalls, however, may not be caused by the 
lack of more explicit approaches to equity or more formal, deliberative processes within 
treatment programs.  They may be caused by something more fundamental.  As Alvarez (2007: 
432) has observed, for example, in similar settings of extreme resource scarcity: 
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“Some resource scarcities are too severe and way below the amount that can sustain a 
decent level of health that they undermine any attempt to make allocation ethical….”  
 
Perhaps, when the gap between need and capacity is so large, there can be no such thing as an 
ethical approach.  What emerges are approaches that are pragmatic and expedient and that try to 
give a limited benefit to as many as possible without engaging intractable questions of which 
individuals to choose and which not.  It may be that measuring equity and fairness in such 
situations is at best fruitless or, worse, irrelevant. 
 
While selection criteria and selection processes help facilitate difficult work in rationing 
dilemmas by attempting to make the outcome of such choices as fair and equitable as possible, 
they also serve other ends.  With respect to ART, they also balance risk.  An ART program 
improperly implemented or controlled runs the risk of encouraging the development and spread 
of treatment-resistant strains of HIV.  While this has not yet emerged in Lesotho (there is no 
technology in-country at the moment to examine this), the rise of XDR-TB in the region is a 
striking reminder that it could given how this very dangerous form of TB arises from poor 
adherence to TB treatment regimens and poorly administered first-line TB treatment programs.  
Using a process like the one at St. Charles sets a certain pace for how many people can move 
through the various stages of preparation and end up on treatment within the limits of a standard 
working day or a standard working week.  The team is not, at the moment, inundated with 
individuals seeking ART (elsewhere in Lesotho there are treatment sites that are).  If it wanted to 
significantly improve the coverage of the ART program, much bolder steps are required than 
 
 
 
 
 
 
38
tinkering with eligibility criteria or the number of steps in the selection process.  To reach 
significantly more people with ART perhaps only a minimum of steps are required and a new 
balancing of the risk equation.  What would the outcome be of much wider access and much 
fewer eligibility steps?  Some individuals would die from not taking their treatment properly.  
Some individuals would develop drug resistant virus and potentially transmit it to others.  Would 
these risks be balanced, though, by a significantly greater number of people taking treatment and 
doing it correctly over the long term? As Rosen et al. (2007: 1695,1698) have noted, early 
experience with long term retention of patients in ART programs in sub-Saharan Africa is not 
encouraging, suggesting, perhaps, that the current approach to preparing patients for treatment is 
not having its intended effect.  At the moment, the balance between individual entitlement to the 
means for health improvement and the need for an overall public health benefit through a well 
managed ART program is not being met.9  As long as this is the case, the premises underlying 
ART program design should be revisited.  This should be done with a view to examining 
whether the balance between the public health objective of a well-administered treatment 
program and individual entitlement to the means to preserve life and health with only the 
minimal necessary restrictions is correctly proportioned.  Surely, given the consequences of not 
receiving ART in a timely way and given the great number of those not yet receiving ART, the 
analysis should lead us to skew this balance in favour of those individuals whose lives will be 
lost unless some radical changes are made. 
 
Commenting on the performance of a treatment team that functions in the midst of such 
                                                          
9It was recently estimated in Free State, South Africa, a region adjacent to Lesotho and near Seboche, that 87% of 
those who qualified for treatment according to eligibility criteria similar to those use by St. Charles were not 
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quandaries is a delicate matter.  The ART program at St. Charles operates within a larger health 
system that does not substantially address equity.  On the question of ethical inconsistencies in 
the selection process, one must ask to what extent these are significant barriers when placed 
beside the constraints of stigma, literacy, cultural beliefs, poverty and geography.  To what 
extent would bringing forward inconsistencies and conflicts disrupt relationships and damage the 
functioning of the team for an increase in access to treatment that may only be marginal in the 
face of more powerful forces keeping individuals away?  Health care professionals are highly 
educated individuals who must balance a number of important aspects in their daily work of 
providing care and treatment.  Rarely can a health care worker hide behind the screen of doing 
only what the national guidelines said or what the national program director demanded when, in 
the context of patient care, problems and inconsistencies arise that, in extreme cases, prevent 
access to care.  The services they provide and the care they give must not only be competent and 
effective, they must also be ethical.  At St. Charles, the team is not well equipped to deal with the 
ethical challenges it faces.  There is pressure nationally to just keep moving, to keep putting 
individuals on treatment.  While this may utilize the limited capacity of the team more or less 
effectively in the short term, there is no ability to measure what impact the program will have 
over the long term.   
 
Which essential aspects of the communities around St. Charles will be preserved by the ART 
program, which will not?  There is little support for the team for reflection and dialogue on this 
challenge.  One of the issues to be explored at the outset of the study was whether the ethical 
concepts of fairness and equity had operative value or ‘traction’ in the daily work of the 
                                                                                                                                                                                           
currently receiving it (SABC 2007). 
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treatment team.  One must conclude from the study that they do and they do not.   There is an 
awareness of these things across the team even is if there is not, necessarily, the means to fully 
implement in the treatment program what such concepts demand.   On the other hand, 
circumstances surrounding the treatment program at St. Charles may be such that equity and 
fairness have little relevance and shed little light for them on how to better accomplish their 
difficult task.     
 
b)  Study Participant Feedback 
 
As part of the study design, a summary of the findings, including the ethical reflection and the 
conclusions and recommendations, was presented to the treatment team in January, 2008.  The 
aim of the session was to enable the research to confirm the conclusions of the study and to 
prompt the treatment team to engage in some additional reflection on their work.  Not all of those 
originally interviewed attended the session.  Overall, the session validated the findings of the 
research.  The team has very little opportunity to reflect on what it does and rarely does so in 
relation to ethical concepts raised by the work that they do.  There was general agreement that 
such reflection is very helpful at identifying challenges and guiding improvements.  When the 
estimate of overall need for treatment and care was placed before the team, there was general 
silence.  There is awareness that many of those who need care do not access it.  There is perhaps 
a sense of sadness and defeat given the multiple challenges that surround the ART program.  The 
team, nonetheless, believes in the benefit that it provides and is encouraged by the growing 
number of those on treatment and by the efforts they make for many individuals who experience 
problems.   
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c)  Study Limitations 
 
A single case study has limitations.  Broad generalizations are made on the basis of only a single 
instance of a phenomenon.  For that reason, certain findings may be overstated or 
overemphasized.  Much of the data for this enquiry came from key informant interviews.  There 
was little opportunity for external validation of some of the information obtained in the 
interviews. Sufficient data to assess equity was not available.  Any statements and conclusions in 
this respect are therefore tentative.  Some key informants and some important documentation 
were not available during either the site visit or the follow up visits.  For this reason, some 
aspects of the work at St. Charles may not be fully represented in the study.   The study is only a 
partial look at a much larger question.  It could be that other places where ART programs are 
offered have resolved some of the key challenges and dilemmas brought forward in this analysis.  
In a single case study design there is no test for general significance of a finding and the 
likelihood that it reflects a common phenomenon.  That type of finding will have to await a much 
larger, more comprehensive assessment of patient selection processes.   
 
Conclusion 
 
The purpose of this study was to bring forward the experience of a health care team providing 
ART at a rural hospital in Lesotho.  That experience was examined in the light of two ethical 
concepts related to rationing dilemmas in situations of scarcity:  equity and fairness.  Model or 
‘right’ approaches had been proposed by prominent ethical and legal scholars at the outset of the 
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global effort to provide ART in places where it was never available before.  However, the 
approached used by the treatment team in Lesotho appears to have gone in a different direction 
and reflected other front-line experiences of those confronted with the challenged of too much 
need for ART at the community level and not enough capacity to provide it.  There is another 
instance here of the use of a first-come-first-served approach, one that seems to predominate 
over other more complex responses to such rationing problems.   Was this approach fair and 
equitable?  To the treatment team who work in a rural community devastated by HIV disease, the 
answer is yes, as fair and as equitable as it can be given the tremendous social, economic, 
cultural,  and geographic challenges of their region.  One must also add here the lack of direction 
from the national level to do anything other than administer a defined set of criteria to as many 
individuals as possible.  From a larger, analytical perspective, however, the results are much less 
conclusive.      
 
Rationing dilemmas generally, and the specific dilemma of need for ART versus capacity in the 
southern African region, raise fundamental moral challenges that neither law nor ethics can yet 
fully address.  There are a number of normative frameworks that have been put forward but the 
gap remains between these and the real experience of health care teams.  As for ART provision, 
while the global gap is so large between those in need and those who receive treatment, we are 
firmly entrenched in something that is inequitable and unfair, a distance that it is impossible for a 
treatment team and, arguably, the national leadership of a impoverished country to even attempt 
to cross.  While this is the case, as this exploratory case study has attempted to show, there may 
be few reasons to go searching for fair and equitable approaches at the program delivery level.  
Instead, more pragmatic tools are required to enable health care teams to more fully understand 
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the ethical dimensions of what they do in ways that enlighten and empower them to develop 
creative, context-specific approaches to the difficult task they face.  There may indeed by ethical 
problems at this level, and the experience of the treatment team at St. Charles has shown this, but 
these will not be fully resolved until much larger questions of fairness and equity are addressed 
regionally and globally.   
 
Recommendations 
 
Despite the larger challenges and questions raised by the study, there may be some ways to 
improve patient selection at St. Charles and for similar programs in similar settings: 
 
 The health care team should receive some basic orientation to the ethical principles involved 
in selecting patients for ART.  Skills in ethical reflection are an important tool for a health 
care team doing work like the one at St. Charles.  While they may not be able to fully resolve 
their dilemmas, reflection can provide a way of easing tension and pointing towards 
improvements.  
 
 The health care team could strengthen some of the formality and objectivity that should be a 
part of patient selection process.  Criteria could be documented for example in one ‘official’ 
source for the team.  In some cases, it was observed that some individuals were given 
exceptions to eligibility criteria while others were not.  Such decisions should be more explicit 
and formalized to prevent inconsistency. 
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 Some of the eligibility requirements should be reviewed in light of the fact that they differ 
from some of the source documents and may not be justifiable given existing evidence.  This 
involves in particular the requirement to disclose HIV status, to identify a treatment supporter, 
and to attend a minimum of three adherence preparation sessions.  While there is still some 
urgency to increase the number of individuals on treatment, the goal of reflection and review 
should always be in the direction of simplifying selection criteria and processes and 
potentially reducing the number of eligibility steps. 
 
 Data collection should be improved.  The health care team should define ART coverage 
indicators that are easy to capture and then assess them on a regular basis. 
 
This inquiry raises items for further research and action: 
 
 Selection criteria and selection process should continue to be challenged.  Limitations on 
privacy and liberty, even for the most disadvantaged, require adequate justification.  Some 
aspects of patient selection have little or no empirical evidence to justify them. 
 
 Data to assess equity must become more of a priority.  It may be that some original 
aspirations around equity were utopian.  However, there is a large gap at the moment 
preventing even tentative conclusions from being drawn. 
 
 The model for ART delivery should be continually challenged.  The WHO IMAI model 
predominates in Lesotho and elsewhere which emphasizes utilitarian, public health objectives.  
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The adherence preparation process it recommends can be burdensome to some with the result 
that they do not access treatment.  Does this approach achieve the right balance with the rights 
and entitlements of individuals to access what will give them health and preserve their life?  
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APPENDIX A:  ETHICS REVIEW CLEARANCES 
 
 
NOTE:  The original title for the research study was, “Achieving Equity and Fairness in 
Rationing of Access to Anti-Retroviral Care at a Rural Clinic in Lesotho:  A Case Study 
Analysis.”  At the request of the internal assessors review committee, the title was changed to its 
current form.  A new clearance certificate was issued with the amended title.  This was the only 
aspect of the original protocol that was changed.  The research did not, therefore, requested 
amended clearances from the Ministry of Health and Social Welfare, Lesotho, or the St. Charles 
Mission Hospital.
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SEBOCHE MISSION 
HOSPITAL 
ST. CHARLES MISSION P.O. BOX 304 
BOTHA-BOTHE 400 
TEL.: 00266 27 00 58 22 
 
IN PRAYER AND 
CONTEMPLATION WE 
RECEIVE THE VITALITY 
NECESSARY FOR OUR 
APOSTOLIC ACTIVITY 
 
        Dr. med. R. Duerig 
        Med. Sup. 
        Seboche Hospital  
        P.O. Box 304 
        Butha Buthe 400  
        Lesotho 
 
Mr. R. Armstrong 
108 de la Harpe 
Rosendal 9720 
RSA 
 
 
Dear Mr. Armstrong 
 
I am writing in reply to your request of participation in your research project titled: Achieving 
Fairness and Equity in Rationing of Access to Anti-retroviral Care at a Rural Clinic in Lesotho: 
A case study. 
 
We are certainly aware of the discrepancy between the number of patients in need of treatment 
and the capacity of our institution. To provide Equity and Fairness in the selection process 
should be one of the leading aspects of antiretroviral treatment and is one of the hardest aims to 
reach. 
 
We would therefore appreciate if you select our hospital as base of your case study and we will 
support you in all the aspects mentioned in your letter dated June the 29th 2007 and the attached 
research proposal. 
 
Best Regards 
 
Dr. med. R. Duerig 
Med. Sup. Seboche Hospital 
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SELECTING PATIENTS FOR ANTI-RETROVIRAL CARE AT A RURAL CLINIC IN LESOTHO:  A CASE STUDY 
ANALYSIS 
 
PARTICIPANT INFORMATION SHEET 
 
Lumela! 
 
My name is Russell Armstrong and I am a post-graduate student at the Steve Biko Centre for Bioethics, 
University of Witwatersrand in Johannesburg, South Africa.  I am studying for a Masters of Science in 
Medicine in Bioethics and Health Law.  I would like to conduct a research project at your ARV clinic as 
part of the requirements for my degree.  Below is information about my project.  I would like you to 
consider participating in the project with me. 
 
Background 
As a doctor or a nurse or a counsellor involved in the delivery of anti-retroviral (ARV) care for people 
living with HIV/AIDS, you may already be aware that not everyone who needs this treatment is able to 
receive it.   In Lesotho, some criteria have been developed to help select which patients should receive 
ARV treatment (CD4 count <200, for example).  These criteria do not always help, though, as sometimes 
more people meet the criteria than there are spaces available for ARV treatment.  Sometimes, you and 
your colleagues have to make choices and decide who should get treatment now and who should continue 
to wait. 
 
Purpose 
The purpose of this project is to investigate how a team of people working at an ARV centre makes 
choices and decides who can receive ARV treatment.  Prominent ethicists and legal scholars around the 
world have suggested that in making choices, we should be trying to achieve equity and fairness.  Equity 
means that the selection process should not be easier for some and harder for others (those who live close 
to your clinic, for example, versus those who live far away).  Fairness means that the process used to 
select patients is based on clear criteria and that the selection process follows the same steps each time.  
This project will investigate whether this is useful advice and whether it helps you to make the selection 
of patients easier. 
 
Research Method 
The research method to be used for this project is called case study.  It is a very in-depth way of looking 
at something and produces a very detailed, multi-dimensional picture.  To do the study, I will be spending 
up to five days at the clinic interviewing you and others, reviewing documents and watching how you 
select your patients for treatment.  If I want to interview you, and you agree, I will ask you to sign a 
consent form.  The consent form says that any information I get from you in an interview is strictly 
confidential.  It also says that if I want to use a quotation from you later in my research report, I need your 
permission first.  If you decide to participate, the interview will last between 45 and 60 minutes in a 
private place at a time that is convenient to you. 
 
Participant Feedback 
Following my time at the clinic, I will take all of my notes and observations and analyse them to see how 
patient selection at your clinic relates to the legal and ethical concepts of equity and fairness described 
above.  Once the analysis is complete, I will return to the clinic to present my findings and to ask you 
what you think of them.  I will also ask you to help me come up with some recommendations both for 
your clinic and for other clinics in Lesotho that have the same challenges.  After the session, I will write a 
final version of the report and a short summary of my findings.  I will share the summary with you and 
will give you a copy of the full report if you request one. 
          …/2
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Ethics Review and Supervision 
My project has been approved by the Post-Graduate Research Committee and Health Research Ethics 
Committee at Faculty of Health Sciences, University of Witwatersrand.  It has also been approved by the 
management of St. Charles Hospital and supported by the STI/HIV&AIDS Directorate.  
 
My project is supervised by Prof. Ames Dhai and Prof. Donna Knapp van Bogaert at the Steve Biko 
Centre for Bioethics.  If, for any reason, you wish to contact them, they can be reached at +27 11 717 
2635, or at Amaboo.Dhai@wits.ac.za or Donna.VanBogaert@wits.ac.za       
 
Benefits and Risks 
If you agree to participate, I hope that my project will help you learn more about the concepts of equity 
and fairness and that this will help to improve the way you select patients for treatment when you simply 
cannot treat everyone who needs it.  I also hope that by allowing me to document and share your 
experience, together we can help other treatment sites improve their selection process as well. 
 
Some people may think that I am trying to judge the way you make difficult choices or to look for 
mistakes in the treatment program.  I want to assure you that I am there to observe and not to judge.  The 
quality of a case study is the way that it documents what is happening and tries to learn from the 
experience.  I have also managed an ARV treatment program in Lesotho.  I know how difficult it is and, 
through my research, want to try to make things easier. 
  
There may be some risks to you if you participate.  I will make every attempt to keep everything you say 
to me confidential.  However, since the treatment site is quite small, even if I don’t identify you as 
the source of some of my information, someone else may guess that it was you who told me.  If this 
concerns you, you can choose not to share sensitive things with me in the interview.  You can choose to 
withdraw your participation at anytime, even during or after the interview.  You can choose not to 
participate at all. 
 
Questions or Concerns 
 
If you have any questions about my project, you can contact me, Russell Armstrong,  
at +266 58020749 or russellarms@gmail.com.  You may also contact my research supervisors, Prof. 
Dhai or Prof. van Bogaert at the coordinates listed above. 
 
If you have any concerns about your rights as a research participant you can contact Anisa Keshav, 
Wits Research Office, at +27 11 717 1234 or anisa.keshav@wits.ac.za.  She will put you in contact 
with Prof. Peter Cleaton-Jones (Chair), Health Research Ethics Committee. 
 
             
        July, 2007 
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SELECTING PATIENTS FOR ANTI-RETROVIRAL CARE AT A RURAL CLINIC IN LESOTHO:  A 
CASE STUDY ANALYSIS 
 
Consent for Interview 
 
I, _________________________, have been asked to participate in this research study.  I have 
received a copy of the Participant Information Sheet from Russell Armstrong.  I have read the 
sheet and understand the purpose of this research project. 
 
I understand that everything I say to Russell during the interview will be kept strictly 
confidential meaning that he cannot share what I say with anyone unless I give my express 
permission. 
 
Russell may use quotations that do not identify me in anyway.  Before the research report is 
finalized, Russell will show me where he has used quotations so that I can know that I am not 
identified as the source of the quote unless I specifically agree. 
 
Russell has explained to me that there may be some risks to me if I participate.  The treatment 
team is small at Seboche and even if Russell does everything he can to protect my 
confidentiality, someone may guess that I have given certain information to him.  I understand 
this risk. 
 
I understand that my participation in the interview is voluntary.  I can choose not to answer any 
questions Russell asks me.  I can end the interview at any time that I wish.  I can also ask that 
Russell destroy his notes and not use any material from the interview if I am dissatisfied in any 
way. 
 
If I have any questions or concerns about Russell’s conduct, I can raise them with the Medical 
Superintendent, Dr. Dürig.  I can also contact Russell’s supervisors directly at the University or I 
can contact the Chair of the Health Research Ethics Committee.  The contact details for these 
individuals are contained in the participant information sheet. 
 
Having read this consent form, having read the participant information sheet, and having heard 
Russell’s explanation of the study and the consent process, I agree to be interviewed for the 
study.   
 
___________________________________________  Date: 
Signature of participant 
 
___________________________________________  Date:  
Signature of researcher (Russell Armstrong) 
 
 
Please sign TWO copies.  One is for you, the participant.  The other is for the researcher. 
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APPENDIX C: 
 
KEY INFORMANT INTERVIEW FRAMEWORK 
 
After obtaining informed consent and reviewing the purpose of the study with the key informant, 
proceed as follows: 
 
Thank you for agreeing to be interviewed.  I have a few questions to get us started.  Basically, I 
am trying to understand how decisions are made by you and your colleagues about who gets to 
receive anti-retroviral therapy.  Please stop me at any time if there is something you don’t 
understand and would like me to clarify.  If a question makes you feel uncomfortable, you are 
free not to answer it.  You are free to stop me at any time and end the interview if you wish.  Are 
you ready? 
 
1. What role do you play in the clinic with respect to giving out anti-retroviral treatment? 
 
2. How do you determine whether someone will receive anti-retroviral therapy?  Tell me 
about each step in the process…. 
 
3. Are there specific criteria that you use?  Can you tell me about them?  Where did they 
come from?  Are there any additional rules that the clinic uses? 
 
4. Do you ever make exceptions to these criteria?  Can you give me an example? 
 
5. Have you ever not given someone anti-retroviral therapy?  Can you tell me why? 
 
6. Have you ever been challenged by a patient who did not get anti-retroviral therapy?  If 
yes, what happened? 
 
7. Do you think that the way the anti-retroviral therapy is given out is fair?  Can you tell me 
what ‘fair’ means to you and how it relates to the decisions you make about who gets 
treatment? 
 
8. If one defines equity as no one having more of a chance than others to get anti-retroviral 
therapy (providing everyone qualifies as defined by the Lesotho guidelines), would you 
say that the way patients receive treatment is equitable?  Are their groups, in your opinion 
that, are favoured over others? 
 
9. Would you put more people on treatment if you could?  If yes, what is preventing you 
from doing this?  If no, why not? 
 
10. Is there anything else you would like to add? 
 
Thank key informant.  Repeat assurances around confidentiality.  Ask for permission to re-
interview if necessary.  Remind informant of how to contact you if they have anything they wish 
to raise later. 
